Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-02-02
1993-10-19
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514451, 514459, 546153, 549416, 549417, 549419, 549420, 549423, 549424, 549425, 549426, 549427, 549428, A61K 3135, C07D30906
Patent
active
052545814
ABSTRACT:
The invention concerns a cyclic ether derivative of the formula I ##STR1## wherein Ar.sup.1 is optionally substituted phenyl, naphthyl or a 9- or 10-membered bicyclic heterocyclic moiety;
REFERENCES:
patent: 2242575 (1941-05-01), Eisleb
patent: 3422102 (1969-01-01), Morren
patent: 3661917 (1972-05-01), Kaiser et al.
patent: 3743737 (1973-07-01), Kaiser et al.
patent: 4876346 (1989-10-01), Musser et al.
patent: 4918081 (1990-04-01), Huang et al.
patent: 4920130 (1990-04-01), Huang et al.
patent: 4920131 (1990-04-01), Huang et al.
patent: 4920132 (1990-04-01), Huang et al.
patent: 4920133 (1990-04-01), Huang et al.
patent: 4929626 (1990-05-01), Mohrs
patent: 4970215 (1990-11-01), Mohrs
Bruneau Pierre A. R.
Dowell Robert I.
Waterson David
ICI Pharma
Imperial Chemical Industries plc
Ivy C. Warren
Turnipseed James H.
LandOfFree
Pyran derivatives and their use as inhibitors of 5-lipoxygenase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyran derivatives and their use as inhibitors of 5-lipoxygenase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyran derivatives and their use as inhibitors of 5-lipoxygenase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1352088